Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Puisieux

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|November 26, 1999
[HNPCC syndrome, microsatellite instability and NF1 gene alteration]A Puisieux
Annales Pharmaceutiques Francaises|December 9, 2008
[Inactivation of failsafe programs by Twist oncoproteins and tumor progression]A Puisieux
Pathologie-Biologie|October 14, 1998
TP53 and hepatocellular carcinomaA Puisieux, M Ozturk
Bulletin Du Cancer|May 26, 1999
[Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis]A Puisieux, J P Magaud
The Biochemical Journal|January 1, 1996
Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanismsA Puisieux, J Ji, M Ozturk
Oncogene|February 1, 1993
p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cellsA Puisieux, F Ponchel, M Ozturk
British Journal of Cancer|November 25, 2005
A twist for survival and cancer progressionA Puisieux, S Valsesia-Wittmann, S Ansieau
Cancer Research|November 15, 1991
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogensA Puisieux, S Lim, J Groopman, et al.
British Journal of Cancer|February 13, 2001
Absence of rearrangements in the BRCA2 gene in human cancersS F Chin, Q Wang, A Puisieux, et al.
Oncogene|April 13, 2010
TWISTing an embryonic transcription factor into an oncoproteinS Ansieau, A-P Morel, G Hinkal, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|November 26, 1999
[HNPCC syndrome, microsatellite instability and NF1 gene alteration]A Puisieux
Annales Pharmaceutiques Francaises|December 9, 2008
[Inactivation of failsafe programs by Twist oncoproteins and tumor progression]A Puisieux
Pathologie-Biologie|October 14, 1998
TP53 and hepatocellular carcinomaA Puisieux, M Ozturk
Bulletin Du Cancer|May 26, 1999
[Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis]A Puisieux, J P Magaud
The Biochemical Journal|January 1, 1996
Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanismsA Puisieux, J Ji, M Ozturk
Oncogene|February 1, 1993
p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cellsA Puisieux, F Ponchel, M Ozturk
British Journal of Cancer|November 25, 2005
A twist for survival and cancer progressionA Puisieux, S Valsesia-Wittmann, S Ansieau
Cancer Research|November 15, 1991
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogensA Puisieux, S Lim, J Groopman, et al.
British Journal of Cancer|February 13, 2001
Absence of rearrangements in the BRCA2 gene in human cancersS F Chin, Q Wang, A Puisieux, et al.
Oncogene|April 13, 2010
TWISTing an embryonic transcription factor into an oncoproteinS Ansieau, A-P Morel, G Hinkal, et al.
Pageof 5